Company Name
Pediatric Bioscience, LLC
Overview
Pediatric Bioscience was formed by a group of researchers, parents and experienced business leaders with the goal of bringing to market diagnostics and therapeutics to diagnose and eventually treat children with autism or autistic spectrum disorder (ASD).
Pediatric Bioscience has licensed three promising technologies from the UC Davis M.I.N.D. Institute, an international, multidisciplinary research organization, committed to excellence, collaboration and hope, striving to understand the causes and develop better treatments and ultimately cures for neurodevelopmental disorders such as autism.
These discoveries may lead to the first early diagnostic test for autism and ASD.
Pediatric Bioscience was created to operate as a lean company with the ability to identify and quickly act upon promising new discoveries. Much of the research and development will be outsourced to trusted partners, with products licensed to existing pharmaceutical and diagnostic companies for distribution.
Market
• 10 million estimated live births in developed countries each year
• Estimated potential annual sales of up to $500 million
Technologies
• Pre-natal auto-immune diagnostic for risk of delivering an autistic child
• Infancy diagnostic for autism allowing for earlier diagnosis than
behavior-based strategies
Leadership
• Dr. Thomas R. Anderson, CEO
— Seasoned biotech entrepreneur
• Mr. Charles Gardner, Founding Chairman
— Principal and Founder of the Hallmark Group
— Credited with being the Visionary behind the M.I.N.D. Institute
— Father of an autistic son
• Dr. David Amaral, Chair of Scientific Advisory Board
— Director of Research, the M.I.N.D. Institute
— World-recognized neurobiologist and autism expert |
